Log in to save to my catalogue

Comparison of the safety and efficacy of the wild-type and lpxL/lpxM mutant inactivated vaccine agai...

Comparison of the safety and efficacy of the wild-type and lpxL/lpxM mutant inactivated vaccine agai...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3153179541

Comparison of the safety and efficacy of the wild-type and lpxL/lpxM mutant inactivated vaccine against the avian pathogenic Escherichia coli O1, O2, and O78 challenge

About this item

Full title

Comparison of the safety and efficacy of the wild-type and lpxL/lpxM mutant inactivated vaccine against the avian pathogenic Escherichia coli O1, O2, and O78 challenge

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2024-04, Vol.42 (10), p.2707-2715

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

AbstractAvian pathogenic Escherichia coli (APEC) is primarily responsible for causing septicemia, pneumonitis, peritonitis, swollen head syndrome, and salpingitis in poultry, leading to significant losses in the poultry sector, particularly within the broiler industry. The removal of the lpxL and lpxM genes led to an eightfold decrease in the endot...

Alternative Titles

Full title

Comparison of the safety and efficacy of the wild-type and lpxL/lpxM mutant inactivated vaccine against the avian pathogenic Escherichia coli O1, O2, and O78 challenge

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3153179541

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3153179541

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2024.03.038

How to access this item